Latest News for: jak inhibitor

Edit

Dose-Intensive CK0804 Regimen Reduces Spleen Volume and Transfusion Needs in JAK Inhibitor-Resistant/ Suboptimal Myelofibrosis with Thrombocytopenia

PR Newswire 10 Dec 2025
"The depth and durability of responses in thrombocytopenic patients who had failed or had suboptimal benefit from prior JAK inhibitor therapy are particularly encouraging and pave way for phase 2 trial.".
  • 1

Article Search

tools
×
×
×
×